Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Oncol Rep ; 45(1): 254-264, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-33210724

RESUMO

In colorectal cancer (CRC), high expression of trefoil factor 3 (TFF3) is associated with tumor progression and reduced patient survival; however, bioinformatics analyses of public 'omics' databases show low TFF3 expression in CRCs as compared to normal tissues. Thus, we examined TFF3 expression in CRCs and matching normal tissues to evaluate its role in CRC progression. TFF3 gene expression was characterized using the bioinformatics portal UALCAN (http://ualcan.path.uab.edu). Tissue microarrays (TMAs) of archival CRC specimens (n=96) were immunostained with anti­human TFF3 antibodies. Immunohistochemical (IHC) staining intensity was semi­quantitatively scored. For this cohort, the median follow­up was 5.4 years. Associations between clinical and pathological variables were determined using Chi­square or Fisher's exact tests. Univariate disease­free survival was estimated by the Kaplan­Meier method. Omics data analyses by UALCAN showed downregulation of TFF3 expression in CRC relative to normal tissue at protein (χ2, P<0.0001) levels. There was a similar decreasing trend of TFF3 expression in the pathologic stages of the CRCs (RNA, χ2, P=0.88 and protein, χ2 P<0.0001). UALCAN data analysis showed that TFF3 exhibited 27% lower mRNA expression in tumors with mutant TP53 (P=0.007). Confirming the findings of omics analyses, IHC analysis of TMAs exhibited lower TFF3 expression in 95.6% (65 of 68) of the available normal­tumor matching pairs (χ2, P<0.0001). There was no statistically significant association of tumor TFF3 expression with patient sex, race/ethnicity, tumor location within the colorectum, Tumor, Node, Metastasis (TNM) stage, lymph node metastasis, or surgical margins. However, low TFF3 IHC staining in tumor tissue was associated with histological grade (P=0.026). Kaplan­Meier survival analysis showed no prognostic value of low TFF3 expression relative to those with high expression (log­rank, P=0.605). Our findings demonstrate low expression of TFF3 in CRCs. Association between low TFF3 and histopathological features suggests involvement of this molecule in progression of CRC.


Assuntos
Neoplasias Colorretais/química , Fator Trefoil-3/análise , Adulto , Idoso , Idoso de 80 Anos ou mais , Neoplasias Colorretais/mortalidade , Neoplasias Colorretais/patologia , Biologia Computacional , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Mutação , Fator Trefoil-3/genética , Proteína Supressora de Tumor p53/análise , Proteína Supressora de Tumor p53/genética
2.
Am Surg ; 69(6): 536-8, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12852516

RESUMO

Pseudomembranes in the gastrointestinal tract are usually associated with the use of antibiotics, steroids, and severe immunosuppression. Reported cases of this condition have usually been confined to the large and small bowel. We discuss a 41-year-old woman who was transferred to The University of Mississippi Medical Center for severe upper gastrointestinal bleeding after admission to an outside facility following a motor vehicle collision. Upper endoscopy revealed an antral ulcer with fungal hyphae found in the biopsy specimen. Because of her exsanguinating hemorrhage from her gastric pathology a total gastrectomy was performed. Pathological inspection of the stomach revealed a green/brown pseudomembranous gastritis throughout the entire stomach. Aspergillus cultures confirmed the etiologic agent. The patient later fell into multiorgan system failure and died. Autopsy results showed no aspergillus in other organ systems. The current literature suggests that this is the first reported case of isolated pseudomembranous gastric aspergillosis.


Assuntos
Aspergilose/complicações , Gastrite/microbiologia , Hemorragia Gastrointestinal/etiologia , Adulto , Antifúngicos/uso terapêutico , Aspergilose/terapia , Evolução Fatal , Feminino , Gastrectomia/métodos , Gastrite/complicações , Gastrite/cirurgia , Hemorragia Gastrointestinal/cirurgia , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA